Drug Topics
MARCH 11, 2025
Non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol levels could potentially be a valuable biomarker for determining the risk of diabetic kidney disease.
PharmaVoice
MARCH 11, 2025
Emalex Biosciences is full steam ahead with a targeted 2026 approval and launch for its novel drug.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
MARCH 11, 2025
IQVIA released a report detailing pharmacists authority to administer vaccines in the US as well as adults overall vaccination rates by state.
STAT
MARCH 11, 2025
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox on Tuesdays and Thursdays. You’re in luck. We’re offering half off STAT+ while supplies last. So hurry. And send tips to John.Wilkerson@statnews.com or via Signal at John_Wilkerson.07.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Drug Topics
MARCH 11, 2025
Researchers investigated the health benefits, utilization, harms, and costs associated with the use of alternative methods for colorectal cancer screening in Australia.
Fierce Healthcare
MARCH 11, 2025
The House of Representatives voted to advance a six month government funding that includes hospital pay extensions but excludes a doc pay fix. The bill now moves to the Senate.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Viseven
MARCH 11, 2025
The eWizard team is excited to announce the release of our latest update, packed with expanded features, new capabilities, enhancements, and more! We remain committed to enhancing eWizard content experience platform , positioning it as the essential tool for businesses ready to elevate their content marketing strategies. As always, our update includes a variety of features designed for both global and local teams to enhance their daily work.
Drug Topics
MARCH 11, 2025
A conversation with Chelsee Jensen, PharmD, BCPS, director of formulary management at the Mayo Clinic.
The Checkup by Singlecare
MARCH 11, 2025
In a 2024 KFF survey, one out of every eight Americans said they had taken a GLP-1 drug like semaglutide. These are some of the hottest medications for Type 2 diabetes and weight loss in the country, helping millions manage their high blood sugar and weight. Semaglutide imitates a hormone called glucagon-like peptide-1, which stimulates insulin production.
Drug Topics
MARCH 11, 2025
COVID-19 vaccination before a SARS-CoV-2 infection was associated with a 75% reduced likelihood of long COVID symptoms that impact daily functioning among patients between the ages of 5 and 17 years.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Pharmacy Times
MARCH 11, 2025
The study aims to assess how docosahexaenoic acid levels in cerebrospinal fluid relate to both neurodegeneration and cognitive function.
PharmaVoice
MARCH 11, 2025
An opaque system of rebates and discounts makes understanding a drug’s true price near impossible, even for experts. Can efforts to bring transparency into that system now pan out?
Oswald's
MARCH 11, 2025
Theres something magical about vintage candyit brings back childhood memories, simpler times, and the unmistakable joy of unwrapping a sweet treat. At Oswalds Pharmacy in Naperville , we take pride in offering a wide selection of nostalgic candies , allowing you to relive the flavors of the past or introduce them to a new generation. Whether youre reminiscing about your favorite childhood sweets or looking for the perfect retro gift, weve got you covered!
Pharmacy Times
MARCH 11, 2025
The favorable outcomes were observed in the phase 3 AMPLIFY trial.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Pharma Marketing Network
MARCH 11, 2025
Introduction Pharma marketing is constantly evolving, with new digital tools, regulatory updates, and data-driven strategies shaping the industry. Staying ahead requires access to reliable resources that help teams navigate the complexities of compliance, engagement, and campaign effectiveness. However, with so much information available, finding the right resources can feel overwhelming.
Fierce Healthcare
MARCH 11, 2025
Hospitals would lead the way with $31.9 billion of lost revenue and a $6.3 billion increase in uncompensated care burden in a scenario where Congress' Medicaid cuts push all states to drop their expansions, Urban Institute analysts found.
The Checkup by Singlecare
MARCH 11, 2025
Zonisamide (brand Zonegran ) is a generic prescription drug used to prevent and control partial epileptic seizures. This anticonvulsant drug is often used alongside other anti-seizure drugs rather than by itself. Without insurance, Zonisamide costs about $92 for 60, 100 mg capsules. While there arent any over-the-counter (OTC) alternatives, there are ways to make Zonisamide more affordable.
Fierce Healthcare
MARCH 11, 2025
Digital physical therapy company Hinge Health filed to go public Monday, signaling a potential revival of the dormant digital health IPO market. | Digital physical therapy company Hinge Health filed to go public Monday, signaling a potential revival of the dormant digital health IPO market.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
STAT
MARCH 11, 2025
My cousin and I were signing my aunt out of the memory care facility to go into town for breakfast. When the aide at the front reception recognized me as an unfamiliar face, she asked my aunt, “Who’s come to visit you today?” My aunt smiled. “That’s my grandson.
Pharmaceutical Technology
MARCH 11, 2025
AWSs framework will speed up the analysis of ElevateBios large protein datasets, hinting at promising drug candidates.
STAT
MARCH 11, 2025
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning, let’s get straight into another busy news day.
Pharmaceutical Technology
MARCH 11, 2025
The multi-year manufacturing deal with CordenPharma will secure future supply of VK2735 if it goes to market.
Pharmacy Times
MARCH 11, 2025
Results of the POETYK PsA-2 trial indicate deucravacitinibs effectiveness at reducing the severity and burden of symptoms in patients with psoriatic arthritis.
pharmaphorum
MARCH 11, 2025
Bristol Myers Squibb has moved to take full control of the CAR-T therapy it partners with 2seventy bio, agreeing to buy the biotech for around $286m
Pharmacy Times
MARCH 11, 2025
Vepdegestrant is an experimental oral PROteolysis TArgeting Chimera that degrades estrogen receptor (ER) in patients with metastatic breast cancer.
pharmaphorum
MARCH 11, 2025
Pfizer and Arvinas' much-anticipated oral SERD vepdegestrant for breast cancer missed a key endpoint in its first phase 3 readout
Pharmacy Times
MARCH 11, 2025
Although improvements were observed in blood pressure (BP) medication adherence, there were no improvements in stain or glucose-lowering medication use.
pharmaphorum
MARCH 11, 2025
Lila Sciences has emerged with $200m in seed financing to advance its vision of AI-powered, fully autonomous labs to power scientific advances
Pharmacy Times
MARCH 11, 2025
Though rare and typically presenting as transient, a case study demonstrates severe, chronic neutropenia in a patient with multifocal motor neuropathy treated with intravenous immunoglobulin (IVIG).
Pharmaceutical Technology
MARCH 11, 2025
The deal comes after a challenging few years for 2seventy bio, which had divested research programmes in recent years.
Fierce Healthcare
MARCH 11, 2025
Hims & Hers acquired Apostrophe for $190 million in 2021. It has since released its own dermatology products through its asynchronous telehealth model and is now shutting down the brand to "simplify" its dermatology products and operations, a spokesperson said.
Pharmaceutical Technology
MARCH 11, 2025
Lundbeck has gained ODD from Japans Ministry of Health, Labor and Welfare (MHLW) for amlenetug to treat multiple system atrophy (MSA).
Pharmaceutical Commerce
MARCH 11, 2025
In the first part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Jason C. Foster, CEO of Ori Biotech, offers his perspective on the state of CGTs, along with their potential for transforming medicine.
Expert insights. Personalized for you.
423 
Let's personalize your content